Blood cancer (ALL leukaemia)
Effectiveness of oral maintenance treatment with 6-mercaptopurine and methotrexate in patients with relapsed or treatment-resistant B-cell acute lymphoblastic leukemia after CAR-T cell therapy.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Registry summary (technical)
A single arm, phase II study to evaluate the efficacy of oral maintenance therapy with 6 mercaptopurine and methotrexate in patients of relapsed/refractory (R/R)-B ALL with early loss of B-cell aplasia post CAR-T infusion. - CAMPER
Sponsor: Tata Memorial Hospital
CTRI/2026/03/105745 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 1 Jun 2026 · read by us 5 Nov 2026